Floatz logo

dt-7012

Cutaneous T Cell Lymphoma (CTCL)

Assistance Publique - Hôpitaux de Parismonoclonal_antibodyEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

61 Active assets in the Cutaneous T Cell Lymphoma (CTCL) cohort.

Asset / SponsorPhaseRating
(+)-VINCRISTINE
Shanghai Jiao Tong University School of Medicine
Phase 4BBB
Cyclophosphamide
Shanghai Jiao Tong University School of Medicine
Phase 4BBB
Bexarotene
Case Comprehensive Cancer Center
Phase 4BBB
DEXAMETHASONE
National Cancer Institute (NCI)
Phase 2BBB
FILGRASTIM
City of Hope Medical Center
Phase 4BBB

View all 50 →

Same molecule, other indications

dt-7012 is also rated in:

cancerDormant
CC
Indicative ·
40 / 100
View asset →
mycosis fungoidesDormant
C
Indicative ·
38 / 100
View asset →
Sezary syndromeDormant
C
Indicative ·
38 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →